GGrantIndex
Sort

59,101 grants matching hypertension

Southeast Collaborative for Innovative and Equitable Solutions to Chronic Disease Disparities

$2,454,140
Consuelo Hopkins Wilkins · Vanderbilt University Medical Center · P50 · FY2024 · MD

Noninvasive Neonatal Blood Gas Monitoring

$2,453,962
Conor Lee Evans · Massachusetts General Hospital · R01 · FY2025 · HD

Neuro-Ophthalmology Research Disease Investigator Consortium (NORDIC) Network

$2,450,886
Mark J Kupersmith · St. Luke'S-Roosevelt Inst For Hlth Scis · U10 · FY2010 · EY

Pannexin Channels In Vascular Physiology & Inflammation

$2,450,733
Kodi S Ravichandran · University Of Virginia · P01 · FY2020 · HL

Chronic Hypertension and Pregnancy-CHAP Clinical Coordinating Center

$2,447,779
Alan Thevenet N. Tita · University Of Alabama At Birmingham · U01 · FY2014 · HL

Vasoactive Autacoids in Blood Pressure Regulation

$2,447,004
Oscar A. Carretero · Henry Ford Health System · P01 · FY2007 · HL

Vasoactive Autacoids in Blood Pressure Regulation

$2,447,004
Oscar A. Carretero · Henry Ford Health System · P01 · FY2010 · HL

Vasoactive Autacoids in Blood Pressure Regulation

$2,447,004
Oscar A. Carretero · Henry Ford Health System · P01 · FY2011 · HL

Vasoactive Autacoids in Blood Pressure Regulation

$2,447,004
Oscar A. Carretero · Henry Ford Health System · P01 · FY2009 · HL

P-CARRS-BRAIN: Multi-domain (genetic, socio-behavioral, vascular) risk factors and prediction of Alzheimer’s Disease continuum in South Asians in India

$2,442,538
Kabayam M Venkat Narayan · Emory University · R01 · FY2025 · AG

Identifying causal gene programs for vascular disease using high throughput CRISPR genomics

$2,442,173
Thomas None Quertermous · Stanford University · P01 · FY2025 · HL

Vascular Subphenotypes of Lung Disease

$2,437,938
Mark Thomas Gladwin · University Of Pittsburgh At Pittsburgh · P01 · FY2013 · HL

AIDS Linked to the IntraVenous Experience (ALIVE)

$2,437,098
Shruti H Mehta · Johns Hopkins University · U01 · FY2023 · DA

AIDS Linked to the IntraVenous Experience (ALIVE)

$2,436,595
Shruti H Mehta · Johns Hopkins University · U01 · FY2024 · DA

Pannexin Channels In Vascular Physiology & Inflammation

$2,436,333
Douglas A Bayliss · University Of Virginia · P01 · FY2022 · HL

Pannexin Channels In Vascular Physiology & Inflammation

$2,436,333
Douglas A Bayliss · University Of Virginia · P01 · FY2023 · HL

Pannexin Channels In Vascular Physiology & Inflammation

$2,436,333
Douglas A Bayliss · University Of Virginia · P01 · FY2021 · HL

Asian Cohort for Alzheimer's Disease (ACAD)

$2,435,808
Li-San Wang · University Of Pennsylvania · R56 · FY2021 · AG

Autocoids in Hypertension: Pathogenesis and End Organ Damage

$2,435,234
Oscar A. Carretero · Henry Ford Health System · P01 · FY2015 · HL

Asian Cohort for Alzheimer's Disease (ACAD)

$2,433,350
Li-San Wang · University Of Pennsylvania · R56 · FY2020 · AG

A Revolutionary Approach for Polycystic Kidney Disease: Oral Nanotherapeutics

$2,433,330
Eun Ji Paige Chung · University Of Southern California · DP2 · FY2018 · DK

Protective Mechanisms In Cerebral Ischemia

$2,431,459
John Hallenbeck · National Institute Of Neurological Disorders And Stroke · ZIA · FY2014 · NS

General Clinical Research Center

$2,428,731
Sheldon M Retchin · Virginia Commonwealth University · M01 · FY2009 · RR

Genetic Epidemiological Studies of Alzheimer Disease

$2,424,683
Boston University Medical Campus · R01 · FY2003 · AG

Psychosocial Factors and Cardiovascular Disease

$2,423,545
Joseph E. Schwartz · Columbia University Health Sciences · P01 · FY2013 · HL